Table 3.
Subgroup analyses: Adjusted risk of death in transplant recipients compared with patients who remained on dialysis
Subgroup | Hazard Ratio for Transplant within Subgroup (95% CI) |
---|---|
All patients | 0.60 (0.53 to 0.68) |
Age, yr | |
<40 | 0.44 (0.32 to 0.61) |
40–49 | 0.49 (0.38 to 0.63) |
50–59 | 0.49 (0.39 to 0.61) |
60–64 | 0.52 (0.38 to 0.70) |
65–69 | 0.60 (0.40 to 0.91) |
Women | 0.38 (0.31 to 0.46) |
Men | 0.58 (0.50 to 0.68) |
Race | |
White non-Hispanic | 0.51 (0.39 to 0.67) |
White Hispanic | 0.46 (0.34 to 0.62) |
Black | 0.46 (0.34 to 0.63) |
Diabetes as cause of kidney failure | 0.73 (0.58 to 0.93) |
Other causes | 0.56 (0.49 to 0.65) |
Panel reactive antibody, % | |
0 | 0.61 (0.49 to 0.75) |
1–79 | 0.60 (0.49 to 0.72) |
80–89 | 0.74 (0.42 to 1.32) |
90–98 | 0.96 (0.60 to 1.52) |
99–100 | 0.60 (0.53 to 0.68) |
Expected post-transplant survival, % | |
1–20 | 0.49 (0.35 to 0.67) |
21–40 | 0.51 (0.39 to 0.65) |
41–60 | 0.69 (0.53 to 0.90) |
61–80 | 0.60 (0.46 to 0.78) |
81–100 | 0.75 (0.58 to 0.97) |
Multivariate model adjusted for differences in patient age, sex, race, cause of kidney disease, body mass index in kilograms per meter2, comorbid conditions, sensitization, and year of first chronic dialysis treatment. 95% CI, 95% confidence interval.